Stem Cell Implants Show Promise For Treating Torn Tendons

April 02, 1997

Cincinnati -- People who suffer serious tendon injuries like President Clinton's might recover more quickly and more completely using a new treatment being tested by researchers in the University of Cincinnati College of Engineering. The treatment was developed by Osiris Therapeutics, Inc. of Baltimore.

The treatment is based on human mesenchymal stem cells, embryonic-like cells responsible for the formation of cartilage, bone, muscle, tendons, ligaments and other connective tissue. Osiris is developing therapies using a patient's own stem cells to regenerate tissue damaged by injuries or disease. Normally, the healing process is very slow and inefficient because there are so few stem cells available.

Preliminary research results using animal models indicate that stem cell implants dramatically reduce the time required for healing following tendon surgery. Randell Young, the manager of preclinical studies for Osiris, said experiments showed "a significant increase in tendon repair strength as early as four weeks after surgery" with continued improvement up to 12 weeks after surgery.

David Butler, a professor of engineering mechanics at the University of Cincinnati, found that stem cells could regenerate about two-thirds of normal tendon strength within four weeks. The re-grown tendon could also absorb nearly the same amount of energy as a normal tendon. More important, the quality of tissue was good. "It was a rapid improvement in both quality and quantity of tissue," said Butler.

The preliminary results were reported at the annual meeting of the Orthopaedic Research Society in San Francisco. The next phase of the research will focus on the patellar tendon and the Achilles tendon, because those two tendons are subjected to the greatest amount of force. And as President Clinton will find, the normal recovery time is typically quite long.

"It's going to be debilitating for him," said Butler. "it will be six weeks to three months of rehab. Jogging? He's done with that for quite some time, at least six months."

There are over half a million injuries in the United States each year to patellar, quadriceps, Achilles and rotator cuff tendons. Those numbers are likely to increase in coming years as the number of older Americans increases. "Age is a factor," said Professor Ed Grood, who collaborates with Butler in the Noyes-Giannestras Biomechanics Laboratory at UC. "As you get older, your ligaments and tendons get weaker. They're more susceptible to injury."

The National Institutes of Health just awarded Osiris a two-year $750,000 Small Business Innovation Research (SBIR) grant to continue development of the treatment in collaboration with the University of Cincinnati researchers.

Osiris President and CEO James Burns said he's encouraged by the progress made so far on the research and said the large SBIR grant indicates the National Institutes of Health believes stem cell implants are a promising approach. "The ability to restore patient function to normal within one to two months would provide a substantial breakthrough in the treatment of soft tissue injuries," said Burns.

A key to using mesenchymal stem cells is the way they are implanted into the body. Researchers have found that the cells respond not only to chemical signals inside the body, but also to physical stresses. Therefore, Osiris has developed customized implants which maximize the quality and quantity of new tissue produced. Osiris researchers are also exploring the use of mesenchymal stem cells to regenerate bone, cartilage and muscle.

Human studies are awaiting FDA approval.
-end-


University of Cincinnati

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.